#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14936	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2310	643.7	0	.	n	.	0	A800G	SNP	800	800	A	1140	1140	G	865	G,A	640,167	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14936	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2310	643.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1790	1790	T	852	T,A,G	783,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14936	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2310	643.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1524	1524	C	864	C	807	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27758	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3432	804.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1596	1596	A	970	A,G	910,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27758	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3432	804.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2230	2230	C	851	C	770	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27758	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3432	804.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2304	2304	A	804	A	753	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27758	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3432	804.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2856	2856	C	868	C	824	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27758	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3432	804.9	0	HET	.	.	.	A2038G	.	2038	2038	A	2297	2297	A	801	A,G	569,174	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2192	folP	855	855	100.0	folP.l15.c30.ctg.1	1518	143.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1032	1034	AGC	237;239;240	A;G;C	220;222;220	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5604	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3418	163.2	1	SNP	p	S91F	1	.	.	271	273	TTC	671	673	TTC	221;221;219	T;T;C,T	201;203;200,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5604	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3418	163.2	1	SNP	p	D95G	1	.	.	283	285	GGC	683	685	GGC	217;215;213	G;G;C	199;197;192	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5604	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3418	163.2	1	SNP	p	G95N	0	.	.	283	285	GGC	683	685	GGC	217;215;213	G;G;C	199;197;192	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1806	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1292	139.3	1	SNP	p	G45D	0	.	.	133	135	GGC	472	474	GGC	241;245;247	G;G;C	226;227;226	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	928	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	987	93.1	0	.	n	.	0	A197.	DEL	197	197	A	514	514	A	222	A	210	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5368	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3002	177.9	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1449	1451	GTC	182;184;183	G;T;C	174;174;175	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5368	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3002	177.9	1	SNP	p	D86N	0	.	.	256	258	GAC	555	557	GAC	235;231;233	G,A;A;C	212,1;210;213	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5368	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3002	177.9	1	SNP	p	R87I	0	.	.	259	261	CGT	558	560	CGT	228;226;228	C;G;T	212;208;209	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5368	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3002	177.9	1	SNP	p	S87R	1	.	.	259	261	CGT	558	560	CGT	228;226;228	C;G;T	212;208;209	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5368	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3002	177.9	1	SNP	p	R87W	0	.	.	259	261	CGT	558	560	CGT	228;226;228	C;G;T	212;208;209	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5368	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3002	177.9	1	SNP	p	S88P	0	.	.	262	264	TCC	561	563	TCC	228;223;221	T;C;C	210;207;203	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4506	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2745	163.7	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1374	1376	TGC	213;213;209	T;G;C	202;200;199	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4506	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2745	163.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1584	1586	GGC	216;213;211	G;G;C	197;196;189	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2096	204.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1109	1111	GCA	227;225;227	G;C;A	212;209;213	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2096	204.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1112	1114	ATC	226;227;225	A,T;T;C	209,1;211;208	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2096	204.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1124	1126	GTG	233;236;237	G;T;G	214;216;219	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2096	204.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1124	1126	GTG	233;236;237	G;T;G	214;216;219	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2096	204.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1628	1630	ACC	210;209;207	A;C;C	192;199;197	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2096	204.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1682	1684	GCG	227;227;224	G;C,G,T;G	202;184,2,1;189	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2096	204.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1682	1684	GCG	227;227;224	G;C,G,T;G	202;184,2,1;189	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2096	204.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1805	1807	GGC	207;204;203	G;G;C	192;186;189	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2096	204.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1814	1816	GGC	206;204;205	G;G;C	190;187;191	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4338	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2096	204.0	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1832	1834	TCG	202;202;196	T,G;C;G	134,8;160;159	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5842	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3120	186.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1616	1618	CCG	225;227;226	C;C;G	196;204;197	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2288	porA	1146	1146	99.56	porA.l6.c17.ctg.1	1731	131.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	570	570	C	153	C	142	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1331	221.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	258	260	GAA	242;243;243	G;A;A	219;219;221	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1331	221.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	546	548	GAT	259;259;258	G;A;T	247;247;246	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1331	221.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	669	671	TCA	263;264;267	T;C,T;A	239;240,1;245	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1331	221.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	798	800	GTC	264;265;264	G;T;C	243;242;244	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1331	221.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1128	1130	GCA	241;240;240	G;C;A	225;222;225	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1331	221.2	1	SNP	p	G120K	1	.	.	358	360	AAG	504	506	AAG	254;256;258	A;A;G	239;242;243	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1331	221.2	1	SNP	p	D121N	0	.	.	361	363	GAC	507	509	GAC	256;255;258	G;A;C	242;239;244	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3008	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1331	221.2	1	SNP	p	A121D	1	.	.	361	363	GAC	507	509	GAC	256;255;258	G;A;C	242;239;244	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11018	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4712	233.1	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1908	1910	AAT	245;245;245	A;A;T	230;229;227	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1154	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	997	115.1	1	SNP	p	V57M	1	.	.	169	171	ATG	532	534	ATG	234;237;237	A;T;G	219;222;219	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
